SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cytrx Corp – ‘10-K’ for 12/31/13 – ‘XML’

On:  Tuesday, 3/4/14, at 6:18pm ET   ·   As of:  3/5/14   ·   For:  12/31/13   ·   Accession #:  799698-14-4   ·   File #:  0-15327

Previous ‘10-K’:  ‘10-K’ on 3/11/13 for 12/31/12   ·   Next:  ‘10-K’ on 3/10/15 for 12/31/14   ·   Latest:  ‘10-K’ on 3/27/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/05/14  Cytrx Corp                        10-K       12/31/13   77:9.7M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Form 10-K for Fiscal Year Ending 12/31/2013         HTML   1.30M 
 2: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     46K 
 3: EX-10.22    Material Contract                                   HTML     68K 
 4: EX-10.23    Material Contract                                   HTML     53K 
 5: EX-10.24    Material Contract                                   HTML     53K 
 6: EX-10.25    Material Contract                                   HTML     52K 
 7: EX-10.29    Material Contract                                   HTML     24K 
 8: EX-10.30    Material Contract                                   HTML     24K 
 9: EX-10.31    Material Contract                                   HTML     24K 
10: EX-10.32    Material Contract                                   HTML     26K 
11: EX-23.1     Consent of Experts or Counsel                       HTML     22K 
12: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
13: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
14: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
15: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
54: R1          Document and Entity Information                     HTML     49K 
44: R2          Consolidated Balance Sheets                         HTML     95K 
52: R3          Consolidated Balance Sheets (Parenthetical)         HTML     48K 
56: R4          Consolidated Statements of Operations               HTML     70K 
72: R5          Consolidated Statements of Stockholders' Equity     HTML     71K 
46: R6          Consolidated Statements of Cash Flows               HTML    116K 
51: R7          Nature of Business                                  HTML     28K 
41: R8          Summary of Significant Accounting Policies          HTML     71K 
33: R9          Receivables                                         HTML     26K 
73: R10         Prepaid and Other Assets                            HTML     23K 
58: R11         Short-term Investments                              HTML     27K 
57: R12         Equipment and Furnishings                           HTML     31K 
62: R13         Accrued Expenses and Other Current Liabilities      HTML     31K 
63: R14         Warrant Liabilities                                 HTML     36K 
61: R15         Commitments and Contingencies                       HTML     51K 
64: R16         Equity Transactions                                 HTML     33K 
53: R17         Investments in ADVENTRX Pharmaceuticals             HTML     26K 
55: R18         Stock Options and Warrants                          HTML    221K 
60: R19         Sale of Assets                                      HTML     23K 
77: R20         Stockholder Protection Rights Plan                  HTML     25K 
67: R21         Income Taxes                                        HTML     58K 
48: R22         Quarterly Financial Data (Unaudited)                HTML     48K 
59: R23         Subsequent Events                                   HTML     59K 
50: R24         Schedule Ii - Valuation and Qualifying Accounts     HTML     40K 
27: R25         Summary of Significant Accounting Policies          HTML    124K 
                (Policies)                                                       
68: R26         Summary of Significant Accounting Policies          HTML     47K 
                (Tables)                                                         
74: R27         Equipment and Furnishings (Tables)                  HTML     29K 
37: R28         Accrued Expenses and Other Current Liabilities      HTML     30K 
                (Tables)                                                         
36: R29         Warrant Liabilities (Tables)                        HTML     34K 
39: R30         Commitments and Contingencies (Tables)              HTML     45K 
40: R31         Stock Options and Warrants (Tables)                 HTML    218K 
42: R32         Income Taxes (Tables)                               HTML     53K 
26: R33         Quarterly Financial Data (Unaudited) (Tables)       HTML     46K 
65: R34         Subsequent Events (Tables)                          HTML     58K 
47: R35         Nature of Business (Details)                        HTML     40K 
49: R36         Summary of Significant Accounting Policies          HTML     67K 
                (Details)                                                        
30: R37         Receivables (Details)                               HTML     23K 
76: R38         Prepaid and Other Assets (Details)                  HTML     23K 
22: R39         Short-term Investments (Details)                    HTML     26K 
43: R40         Equipment and Furnishings (Details)                 HTML     34K 
71: R41         Accrued Expenses and Other Current Liabilities      HTML     35K 
                (Details)                                                        
29: R42         Warrant Liabilities (Details)                       HTML     41K 
35: R43         Commitments and Contingencies (Details)             HTML     83K 
38: R44         Equity Transactions (Details)                       HTML     49K 
45: R45         Investments in ADVENTRX Pharmaceuticals (Details)   HTML     32K 
25: R46         Stock Options and Warrants (Details)                HTML    304K 
32: R47         Sale of Assets (Details)                            HTML     24K 
23: R48         Stockholder Protection Rights Plan (Details)        HTML     33K 
70: R49         Income Taxes (Details)                              HTML     96K 
28: R50         Quarterly Financial Data (Unaudited) (Details)      HTML     37K 
66: R51         Subsequent Events (Details)                         HTML     87K 
31: R52         Schedule Ii - Valuation and Qualifying Accounts     HTML     32K 
                (Details)                                                        
75: XML         IDEA XML File -- Filing Summary                      XML    100K 
24: EXCEL       IDEA Workbook of Financial Reports                  XLSX    171K 
34: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.26M 
16: EX-101.INS  XBRL Instance -- cytr-20131231                       XML   1.91M 
18: EX-101.CAL  XBRL Calculations -- cytr-20131231_cal               XML    190K 
19: EX-101.DEF  XBRL Definitions -- cytr-20131231_def                XML    469K 
20: EX-101.LAB  XBRL Labels -- cytr-20131231_lab                     XML   1.57M 
21: EX-101.PRE  XBRL Presentations -- cytr-20131231_pre              XML    873K 
17: EX-101.SCH  XBRL Schema -- cytr-20131231                         XSD    162K 
69: ZIP         XBRL Zipped Folder -- 0000799698-14-000004-xbrl      Zip    166K 


‘XML’   —   IDEA XML File — Filing Summary


This Document is an IDEA XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<Version> 2.4.0.8 </Version>
<ProcessingTime/>
<ReportFormat> Html </ReportFormat>
<ContextCount> 180 </ContextCount>
<ElementCount> 291 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 47 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 6 </UnitCount>
<MyReports>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 000100 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/DocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
</Report>
<Report>
<IsDefault> true </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 010000 - Statement - CONSOLIDATED BALANCE SHEETS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ConsolidatedBalanceSheets </Role>
<ShortName> CONSOLIDATED BALANCE SHEETS </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> CONSOLIDATED BALANCE SHEETS (Parenthetical) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ConsolidatedStatementsOfOperations </Role>
<ShortName> CONSOLIDATED STATEMENTS OF OPERATIONS </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 030000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ConsolidatedStatementsOfStockholdersEquity </Role>
<ShortName> CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ConsolidatedStatementsOfCashFlows </Role>
<ShortName> CONSOLIDATED STATEMENTS OF CASH FLOWS </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 060100 - Disclosure - Nature of Business </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/NatureOfBusiness </Role>
<ShortName> Nature of Business </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 060200 - Disclosure - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/SummaryOfSignificantAccountingPolicies </Role>
<ShortName> Summary of Significant Accounting Policies </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 060300 - Disclosure - Receivables </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/Receivables </Role>
<ShortName> Receivables </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 060400 - Disclosure - Prepaid and Other Assets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/PrepaidAndOtherAssets </Role>
<ShortName> Prepaid and Other Assets </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 060500 - Disclosure - Short-term Investments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ShorttermInvestments </Role>
<ShortName> Short-term Investments </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 060600 - Disclosure - Equipment and Furnishings </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/EquipmentAndFurnishings </Role>
<ShortName> Equipment and Furnishings </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 060700 - Disclosure - Accrued Expenses and Other Current Liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilities </Role>
<ShortName> Accrued Expenses and Other Current Liabilities </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 060800 - Disclosure - Warrant Liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/WarrantLiabilities </Role>
<ShortName> Warrant Liabilities </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 060900 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/CommitmentsAndContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 061000 - Disclosure - Equity Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/EquityTransactions </Role>
<ShortName> Equity Transactions </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 061100 - Disclosure - Investments in ADVENTRX Pharmaceuticals </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/InvestmentsInAdventrxPharmaceuticals </Role>
<ShortName> Investments in ADVENTRX Pharmaceuticals </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 061200 - Disclosure - Stock Options and Warrants </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/StockOptionsAndWarrants </Role>
<ShortName> Stock Options and Warrants </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 061300 - Disclosure - Sale of Assets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/SaleOfAssets </Role>
<ShortName> Sale of Assets </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 061400 - Disclosure - Stockholder Protection Rights Plan </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/StockholderProtectionRightsPlan </Role>
<ShortName> Stockholder Protection Rights Plan </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 061500 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/IncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 061600 - Disclosure - Quarterly Financial Data (unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/QuarterlyFinancialDataUnaudited </Role>
<ShortName> Quarterly Financial Data (unaudited) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 061700 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/SubsequentEvents </Role>
<ShortName> Subsequent Events </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 061800 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ScheduleIiValuationAndQualifyingAccounts </Role>
<ShortName> SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesPolicies </Role>
<ShortName> Summary of Significant Accounting Policies (Policies) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesTables </Role>
<ShortName> Summary of Significant Accounting Policies (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 080600 - Disclosure - Equipment and Furnishings (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/EquipmentAndFurnishingsTables </Role>
<ShortName> Equipment and Furnishings (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 080700 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables </Role>
<ShortName> Accrued Expenses and Other Current Liabilities (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 080800 - Disclosure - Warrant Liabilities (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/WarrantLiabilitiesTables </Role>
<ShortName> Warrant Liabilities (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 080900 - Disclosure - Commitments and Contingencies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/CommitmentsAndContingenciesTables </Role>
<ShortName> Commitments and Contingencies (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 081200 - Disclosure - Stock Options and Warrants (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/StockOptionsAndWarrantsTables </Role>
<ShortName> Stock Options and Warrants (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 081500 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/IncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 081600 - Disclosure - Quarterly Financial Data (unaudited) (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/QuarterlyFinancialDataUnauditedTables </Role>
<ShortName> Quarterly Financial Data (unaudited) (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 081700 - Disclosure - Subsequent Events (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/SubsequentEventsTables </Role>
<ShortName> Subsequent Events (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 090100 - Disclosure - Nature of Business (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/NatureOfBusinessDetails </Role>
<ShortName> Nature of Business (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 090200 - Disclosure - Summary of Significant Accounting Policies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesDetails </Role>
<ShortName> Summary of Significant Accounting Policies (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 090300 - Disclosure - Receivables (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ReceivablesDetails </Role>
<ShortName> Receivables (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 090400 - Disclosure - Prepaid and Other Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/PrepaidAndOtherAssetsDetails </Role>
<ShortName> Prepaid and Other Assets (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 090500 - Disclosure - Short-term Investments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ShorttermInvestmentsDetails </Role>
<ShortName> Short-term Investments (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 090600 - Disclosure - Equipment and Furnishings (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/EquipmentAndFurnishingsDetails </Role>
<ShortName> Equipment and Furnishings (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 090700 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails </Role>
<ShortName> Accrued Expenses and Other Current Liabilities (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 090800 - Disclosure - Warrant Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/WarrantLiabilitiesDetails </Role>
<ShortName> Warrant Liabilities (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 090900 - Disclosure - Commitments and Contingencies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/CommitmentsAndContingenciesDetails </Role>
<ShortName> Commitments and Contingencies (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 091000 - Disclosure - Equity Transactions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/EquityTransactionsDetails </Role>
<ShortName> Equity Transactions (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 091100 - Disclosure - Investments in ADVENTRX Pharmaceuticals (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/InvestmentsInAdventrxPharmaceuticalsDetails </Role>
<ShortName> Investments in ADVENTRX Pharmaceuticals (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 091200 - Disclosure - Stock Options and Warrants (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/StockOptionsAndWarrantsDetails </Role>
<ShortName> Stock Options and Warrants (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 091300 - Disclosure - Sale of Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/SaleOfAssetsDetails </Role>
<ShortName> Sale of Assets (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 091400 - Disclosure - Stockholder Protection Rights Plan (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/StockholderProtectionRightsPlanDetails </Role>
<ShortName> Stockholder Protection Rights Plan (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 091500 - Disclosure - Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/IncomeTaxesDetails </Role>
<ShortName> Income Taxes (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 091600 - Disclosure - Quarterly Financial Data (unaudited) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/QuarterlyFinancialDataUnauditedDetails </Role>
<ShortName> Quarterly Financial Data (unaudited) (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 091700 - Disclosure - Subsequent Events (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/SubsequentEventsDetails </Role>
<ShortName> Subsequent Events (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 091800 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://cytrx.com/role/ScheduleIiValuationAndQualifyingAccountsDetails </Role>
<ShortName> SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<Logs>
<Log type="Info"> Element us-gaap_DerivativeLiabilitiesCurrent had a mix of decimals attribute values: -3 0. </Log>
<Log type="Info"> Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -5 0. </Log>
<Log type="Info"> Element us-gaap_PropertyPlantAndEquipmentNet had a mix of decimals attribute values: -3 0. </Log>
<Log type="Info"> Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate had a mix of decimals attribute values: 2 3. </Log>
<Log type="Info"> Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant had a mix of decimals attribute values: -6 -5. </Log>
<Log type="Info"> Element us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice had a mix of decimals attribute values: 0 2. </Log>
<Log type="Info"> Element us-gaap_SharePrice had a mix of decimals attribute values: 0 2. </Log>
<Log type="Info"> Element us-gaap_StockIssuedDuringPeriodSharesNewIssues had a mix of decimals attribute values: -5 0. </Log>
<Log type="Info"> 'Monetary' elements on report '090200 - Disclosure - Summary of Significant Accounting Policies (Details)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '090700 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '090900 - Disclosure - Commitments and Contingencies (Details)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Shares' elements on report '091200 - Disclosure - Stock Options and Warrants (Details)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '091200 - Disclosure - Stock Options and Warrants (Details)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '091500 - Disclosure - Income Taxes (Details)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '091600 - Disclosure - Quarterly Financial Data (unaudited) (Details)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> Process Flow-Through: 010000 - Statement - CONSOLIDATED BALANCE SHEETS </Log>
<Log type="Info"> Process Flow-Through: Removing column 'Dec. 31, 2011' </Log>
<Log type="Info"> Process Flow-Through: Removing column 'Dec. 31, 2010' </Log>
<Log type="Info"> Process Flow-Through: 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) </Log>
<Log type="Info"> Process Flow-Through: Removing column 'Jul. 08, 2011' </Log>
<Log type="Info"> Process Flow-Through: 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS </Log>
<Log type="Info"> Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' </Log>
<Log type="Info"> Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' </Log>
<Log type="Info"> Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' </Log>
<Log type="Info"> Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' </Log>
<Log type="Info"> Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' </Log>
<Log type="Info"> Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' </Log>
<Log type="Info"> Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' </Log>
<Log type="Info"> Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' </Log>
<Log type="Info"> Process Flow-Through: 040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS </Log>
</Logs>
<InputFiles>
<File> cytr-20131231.xml </File>
<File> cytr-20131231.xsd </File>
<File> cytr-20131231_cal.xml </File>
<File> cytr-20131231_def.xml </File>
<File> cytr-20131231_lab.xml </File>
<File> cytr-20131231_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies/>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

Top
Filing Submission 0000799698-14-000004   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 6:10:43.1am ET